Retatrutide is a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By activating these receptors, Retatrutide suppresses appetite, {promotesglucose regulation, and ultimately leads to significant weight loss. While studies are still un